Literature DB >> 956696

Hemostatic alterations accompanying sickle cell pain crises.

N Alkjaersig, A Fletcher, H Joist, H Chaplin.   

Abstract

Three patients with sickle-cell disease (SSD) were followed, weekly, for 1 1/2 to 2 years, during which time they experienced one or more episodes of crisis. Crisis was associated with reproducible sequential hemostatic alterations indicating intravascular fibrin formation and a marked disturbance in platelet economy. With crisis onset, or possibly before, there was an increase in plasma high-molecular-weight fibrinogen complexes and a transient fall in platelet count, with a subsequent rise in both fibrinogen concentration and platelet count; plasma fibrinogen peaked 1 week after crisis onset and platelet count approximately 2 weeks after onset. Subsidence of crisis was associated with a fall in high-molecular-weight fibrinogen complexes and a subsequent increase in fibrinogen first derivative, an early fibrinogen breakdown product. Hemostatic findings and patient clinical status were generally correlated, the findings during asymptomatic periods being essentially normal. Agents affecting platelet function (aspirin alone or in combination with dipyridamole) appeared to reduce the extent of laboratory abnormality, suggesting potential clinical usefulness in this disorder.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956696

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Studies of the kallikrein-kinin system in patients with sickle cell anemia.

Authors:  R L Miller; P S Verma; R G Adams
Journal:  J Natl Med Assoc       Date:  1983-06       Impact factor: 1.798

2.  Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Authors:  M W Kenny; A J George; J Stuart
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

3.  Myocardial infarction in sickle cell disease.

Authors:  C R Martin; C S Johnson; C Cobb; D Tatter; L J Haywood
Journal:  J Natl Med Assoc       Date:  1996-07       Impact factor: 1.798

Review 4.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

5.  Formation of soluble fibrin oligomers in purified systems and in plasma.

Authors:  N Alkjaersig; A P Fletcher
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

6.  Tissue type plasminogen activator antigen and activity in sickle cell disease.

Authors:  R B Francis
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

7.  Advances in new drug therapies for the management of sickle cell disease.

Authors:  Kenneth I Ataga; Payal C Desai
Journal:  Expert Opin Orphan Drugs       Date:  2018-05-14       Impact factor: 0.694

8.  The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care.

Authors:  Durjoy K Shome; Ahmed Jaradat; Ahmed I Mahozi; Ali S Sinan; Ali Ebrahim; Mohammed Alrahim; Mohammad S Ebraheem; Eman J Mansoor; Kameela S Majed; Sheikh A Azeez Pasha
Journal:  Indian J Crit Care Med       Date:  2018-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.